Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office
Johnson and Johnson
Merck
Julphar
Baxter

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 7,309,605

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,309,605
Title:Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
Abstract: An isolated DNA encoding the enzyme I-SceI is provided. The DNA sequence can be incorporated in cloning and expression vectors, transformed cell lines and transgenic animals. The vectors are useful in gene mapping and site-directed insertion of genes.
Inventor(s): Dujon; Bernard (Gif sur Yvette, FR), Choulika; Andre (Paris, FR), Perrin; Arnaud (Paris, FR), Nicolas; Jean-Francois (Noisy le Roi, FR)
Assignee: Institut Pasteur (Paris, FR) Universite Pierre et Marie Curie (Paris, FR)
Application Number:10/820,843
Patent Claims:see list of patent claims

Details for Patent 7,309,605

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Institut Pasteur (Paris, FR) Universite Pierre et Marie Curie (Paris, FR) 2012-05-05 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Institut Pasteur (Paris, FR) Universite Pierre et Marie Curie (Paris, FR) 2012-05-05 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Institut Pasteur (Paris, FR) Universite Pierre et Marie Curie (Paris, FR) 2012-05-05 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Express Scripts
Citi
QuintilesIMS
Harvard Business School
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.